Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 154,900 shares, a decline of 27.2% from the November 15th total of 212,800 shares. Based on an average daily volume of 979,800 shares, the days-to-cover ratio is presently 0.2 days.
Reckitt Benckiser Group Stock Up 0.2 %
Shares of OTCMKTS RBGLY traded up $0.02 during mid-day trading on Friday, reaching $12.26. 229,072 shares of the company were exchanged, compared to its average volume of 861,540. Reckitt Benckiser Group has a 1 year low of $10.24 and a 1 year high of $15.03. The firm has a 50-day moving average of $12.33 and a 200 day moving average of $11.73. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97.
Analyst Ratings Changes
RBGLY has been the subject of a number of research reports. Sanford C. Bernstein downgraded Reckitt Benckiser Group from a "strong-buy" rating to a "hold" rating in a research report on Monday, November 4th. Barclays raised shares of Reckitt Benckiser Group to a "strong-buy" rating in a research note on Friday, October 4th. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research report on Wednesday. UBS Group upgraded Reckitt Benckiser Group to a "strong-buy" rating in a research report on Wednesday, September 18th. Finally, HSBC upgraded Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and four have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Buy".
View Our Latest Stock Analysis on RBGLY
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
